FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称STANOZOLOL
异名/同义词17.BETA.-HYDROXY-17.ALPHA.-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOLE
17-METHYL-2'H-5.ALPHA.-ANDROST-2-ENO(3,2-C)PYRAZOL-17.BETA.-OL
17-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOL-17.BETA.-OL
1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)-
2'H-ANDROST-2-ENO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)
ANDROSTANAZOL
ANDROSTANAZOLE
CYCLOPENTA(7,8)PHENANTHRO(2,3-C)PYRAZOL-1-OL, 1,2,3,3A,3B,4,5,5A,6,8,10,10A,10B,11,12,12A-HEXADECAHYDRO-1,10A,12A-TRIMETHYL-
NSC-233046
NSC-43193
STANOZOLOL
STANOZOLOL [EP MONOGRAPH]
STANOZOLOL [GREEN BOOK]
STANOZOLOL [HSDB]
STANOZOLOL [INN]
STANOZOLOL [JAN]
STANOZOLOL [MART.]
STANOZOLOL [MI]
STANOZOLOL [ORANGE BOOK]
STANOZOLOL [USAN]
STANOZOLOL [USP MONOGRAPH]
STANOZOLOL [VANDF]
STANOZOLOL [WHO-DD]
STANOZOLOL CIII
STANOZOLOL CIII [USP-RS]
WIN 14833
WIN-14833
WINSTROL
CAS登记号10418-03-8
物质唯一标识(Unique Ingredient Identifier)4R1VB9P8V3
分子式C21H32N2O
国际化合物标识(International Chemical Identifier,InChI)LKAJKIOFIWVMDJ-IYRCEVNGSA-N
SMILES[C@]12([C@@]3([C@@]([C@@]4(CC[C@@]([C@]4(CC3)C)(O)C)[H])([H])CC[C@]1(Cc5[nH]ncc5C2)[H])[H])C
分子结构式
欧洲化学品管理局注册号(ECHA)233-894-8
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System